Table 2 (abstract P137). Univariate comparison of the characteristics of patients with ≤4 headache days per month (super responders) vs all other treated patients

Age, median (IQR)

54.4 (53-56)

51 (45-54)

0.774

-

Female sex, n (%)

21 (77.6)

71 (86.6)

0.274

0.83 (0.58-1.21)

Migraine years, median (IQR)

44.5 (38-51)

30 (23-45)

0.204

-

Chronic migraine duration (months), median (IQR)

8.5 (5-12)

60 (24-120)

0.061

-

Monthly headache days, median (IQR)

30 (23.5-30)

30 (25-30)

0.093

-

Medication overuse, n (%)

17 (63.0)

68 (87.2)

0.010

0.63 (0.40-0.98)

Allodynia, n (%)

10 (41.7)

24 (34.8)

0.546

0.81 (0.40-1.61)

Unilateral headache, n (%)

12 (44.4)

36 (45.4)

0.960

1.02 (0.53-1.96)

Throbbing headache, n (%)

18 (66.7)

52 (65.0)

0.875

0.95 (0.47-1.89)

Baseline MIDAS score, median (IQR)

106.5 (81-132)

92 (41-180)

0.824

-

Baseline HIT-6 score, median (IQR)

77 (72-82)

66 (61-72)

0.132

-

Baseline VAS score, median (IQR)

9.5 (9-10)

9 (8-10)

0.134

-

Baseline BDI score, median (IQR)

33.5 (30-37)

9 (8-22)

0.059

-

Baseline GAD-7 score, median (IQR)

19 (14-24)

5 (3-14)

0.088

-